Nanotechnology companies usually pertain to those ventures that are focused on harnessing the power of atoms, molecules and supramolecules. These ventures are usually engaged in creating novelty therapeutics and various advancements in medicine and technology.
These businesses are the focus market of Harris & Harris Group. The business is listed as a venture capital firm that continues to support the financial needs of several biopharmaceutical and technology companies in the United States. Since the company’s inception in 1981, it has already made 90 investments. More than 60 of these investments have generated returns and value to its shareholders and consumers.
Harris & Harris is headquartered in New York City. It is listed as a component of the Wilshire 5000 Index. In 1983, the business has made its initial public offering and made its debut on the NASDAQ, where it continues to market its common shares today, using the symbol TINY.